148 related articles for article (PubMed ID: 2503555)
1. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
Mori H; Itoh N; Tamaya T
Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
[TBL] [Abstract][Full Text] [Related]
2. Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascites.
Mori H; Itoh N; Yamada Y; Tamaya T
Biotherapy; 1989; 1(3):123-31. PubMed ID: 2518374
[TBL] [Abstract][Full Text] [Related]
3. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
[TBL] [Abstract][Full Text] [Related]
4. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
5. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
6. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432.
Mori H; Itoh N; Shiraki S; Tamaya T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464
[No Abstract] [Full Text] [Related]
7. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
[TBL] [Abstract][Full Text] [Related]
8. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
Sekimoto M; Kokunai I; Shimano T; Kobayashi T; Takeda T; Haruna N; Yamamoto A; Mori T
J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
[TBL] [Abstract][Full Text] [Related]
9. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
10. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
Katano M; Torisu M
Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854
[TBL] [Abstract][Full Text] [Related]
11. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
Hironaka K; Yamaguchi Y; Okita R; Okawaki M; Nagamine I
Anticancer Res; 2006; 26(5B):3701-7. PubMed ID: 17094388
[TBL] [Abstract][Full Text] [Related]
12. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
Watanabe N; Niitsu Y; Yamauchi N; Neda H; Sone H; Urushizaki I; Yamamoto A; Nagamuta M; Sugawara Y
Immunopharmacol Immunotoxicol; 1988; 10(1):53-65. PubMed ID: 3361071
[TBL] [Abstract][Full Text] [Related]
14. [Effect of malignant ascitic fluids and OK-432 on the induction of LAK activity in peripheral blood mononuclear cells of gynecological cancer patients].
Kanaoka Y; Umesaki N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jun; 43(6):611-8. PubMed ID: 1856521
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue.
Hassan MI; Kassim SK; Saeda L; Laban M; Khalifa A
Anticancer Res; 1999; 19(6C):5657-62. PubMed ID: 10697636
[TBL] [Abstract][Full Text] [Related]
16. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation.
Mori H; Itoh N; Yamada Y; Tamaya T
Asia Oceania J Obstet Gynaecol; 1989 Sep; 15(3):281-9. PubMed ID: 2512905
[TBL] [Abstract][Full Text] [Related]
17. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
Takekoshi H; Oyama R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
19. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
Inagawa H; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
[TBL] [Abstract][Full Text] [Related]
20. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
